Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Mouse macrophages from bone marrow treatment

ABSTRACT:

ORGANISM(S): Mus Musculus

TISSUE(S): Macrophages

PROVIDER: ST000174 | MetabolomicsWorkbench |

REPOSITORIES: MetabolomicsWorkbench

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	mwtab	Other

Items per page:

1 - 1 of 1

Similar Datasets

Metabolic Reprogramming of Mouse Bone Marrow Derived Macrophages Following Erythrophagocytosis.

Project description: Not available

| S-EPMC7204509 | biostudies-literature

Pathways of retinoid synthesis in mouse macrophages and bone marrow cells.

Project description: Not available

| S-EPMC4952016 | biostudies-literature

Mouse bone marrow-derived macrophages (BMDMs) loaded with atherogenic LDL

Project description:While aging is well established as an important risk factor for the development and progression of atherosclerosis, the underlying molecular mechanisms of this relationship remain poorly defined, and its role in atherosclerosis regression is unknown. We investigated the response of bone marrow-derived macrophages isolated from old and young mice to atherogenic aggregated LDL.

2025-05-07 | PXD054290 | Pride

Transcriptomic Changes in Mouse Bone Marrow-Derived Macrophages Exposed to Neuropeptide FF.

Project description: Not available

| S-EPMC8151073 | biostudies-literature

Proteomic Sequencing of Mouse Bone Marrow Macrophages

Project description:Bone marrow macrophages were isolated from CD40-TRAF2/3/5 -/- and CD40-TRAF6 -/- mice, followed by induction of differentiation and maturation. Apoptotic cardiomyocytes were then added to trigger efferocytosis for 3 hours. Subsequently, total proteins were extracted for proteomic sequencing.

2026-03-18 | PXD075780 |

Metformin impacts the differentiation of mouse bone marrow cells into macrophages affecting tumour immunity.

Project description: Not available

| S-EPMC11417223 | biostudies-literature

Prolactin-Releasing Peptide Differentially Regulates Gene Transcriptomic Profiles in Mouse Bone Marrow-Derived Macrophages.

Project description: Not available

| S-EPMC8123224 | biostudies-literature

Mouse bone marrow derived macrophages

Project description:Bone marrow cells (BM) were isolated and primed with M-CSF (M BMDM) or GM-CSF (GM BMDM) for 7 days. M-BMDMs were treated with IL6 (20 ng/ml) for 3 h or 24 h while GM-BMDMs were treated for 3 h. The difference between BM, M-BMDM, and GM-BMDM were analyzed to describe the phenotye and function of each population. Moreover, by RNA-seq analysis, the influence of IL6 treatment on GM-BMDMs and M-BMDMs were analyzed.

2022-10-31 | GSE179637 | GEO

Autophagic reprogramming of bone marrow-derived macrophages.

Project description: Not available

| S-EPMC10060350 | biostudies-literature

Identifying novel LRRK2 substrates in mouse bone marrow-derived macrophages

Project description:LRRK2 is commonly mutated in Parkinson’s disease and has cell type-specific mechanisms of activation and function. In macrophages, LRRK2 is associated with lysosomes and is activated following lysosomal damage. However, the functional outcomes of clinically relevant pathogenic mutations in macrophages are unknown. Here, using primary mouse and patient-derived iPSC-derived macrophage (iPSDM) models of LRRK2-G2019S, we defined the substrates of LRRK2 after lysosomal damage. Using phosphoproteomics we found that LRRK2-G2019S and wild-type macrophages showed similar levels of Rab GTPases phosphorylation after lysosomal damage. However, the levels of pRab12 increased whereas the levels of pRab35 decreased in LRRK2-G2019S macrophages. Functionally, LRRK2-G2019S macrophages showed a deficit in lysosomal membrane repair that resulted in more cell death and increased apoptosis. Importantly, we recapitulated this phenotype in iPSDM from patients carrying the G2019S mutation, but not in isogenic control iPSDM. Altogether, we define here the signaling downstream of G2019S in macrophages and identify susceptibility to cell death after lysosomal damage as an important phenotype of this mutation.

2026-07-09 | PXD050088 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data